LifeSci Biotechnology Products Index
Removal of Component(s) – ARRY
7/30/2019
Today, Pfizer announced that it has closed its previously announced acquisition of Array Biopharma (ARRY). As a result, effective at the market close on Wednesday, July 31, 2019, the value of ARRY will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.
